Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F. M. F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R. J., Muller, M., Elewaut, D., Hammond, C. L., Sanchez, C., & Henrotin, Y. (20 September 2023). Osteomodulin downregulation is associated with osteoarthritis development. Bone Research, 11 (1), 49. doi:10.1038/s41413-023-00286-5 |
Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (30 May 2023). Urolithin A and B accelerate myocyte fusion into myotubes. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1926-1927. doi:10.1136/annrheumdis-2023-eular.3536 |
Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (30 May 2023). Osteomodulin down-regulation is associated with osteoarthritis development. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1194-1195. doi:10.1136/annrheumdis-2023-eular.1006 |
Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (March 2023). Deciphering Urolithins A And B Activities On Muscle: Transcriptomic Modulation On Human Primary Myotubes. Osteoarthritis and Cartilage, 31, 303. doi:10.1016/j.joca.2023.01.316 |
Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (March 2023). Osteomodulin Is Involved In Bone And Cartilage Homeostasis And Osteoarthritis Development. Osteoarthritis and Cartilage, 31, 323-S324. doi:10.1016/j.joca.2023.01.350 |
Uebelhoer, M., Lambert, C., Grisart, J., Guse, K., Plutizki, S., & Henrotin, Y. (2023). Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review. Frontiers in Medicine, 10, 1148623. doi:10.3389/fmed.2023.1148623 |
Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (December 2022). Évaluation de l’activité des urolithines A et B sur le muscle : modulation transcriptomique sur les myotubes primaires humains. Revue du Rhumatisme, 89, 49-A50. doi:10.1016/j.rhum.2022.10.061 |
Zappia, J., Van Der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Lories, R., Elewaut, D., Sanchez, C., & Henrotin, Y. (December 2022). L’ostéomoduline joue un rôle majeur dans l’homéostasie de l’os et du cartilage. Revue du Rhumatisme, 89, 176. doi:10.1016/j.rhum.2022.10.261 |
Sanchez, C., Zappia, J., Lambert, C., FOGUENNE, J., Dierckxsens, Y., Dubuc, J.-E., Delcour, J.-P., Gothot, A., & Henrotin, Y. (11 August 2022). Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.931914 |
Sanchez, C., Zappia, J., Lambert, C., Dierckxsens, Y., Dubuc, J.-E., Delcour, J.-P., & Henrotin, Y. (April 2022). CURCUMA LONGA AND BOSWELLIA SERRATA EXTRACTS MODULATE DIFFERENT AND COMPLEMENTARY PATHWAYS TO EXERT ANTI-INFLAMMATORY, ANTI-OXIDATIVE AND ANTI-CATABOLIC ACTIVITIES ON CHONDROCYTES: DECIPHERING OF A TRANSCRIPTOMIC STUDY. Osteoarthritis and Cartilage, 30 (Suppl 1), 435. doi:10.1016/j.joca.2022.02.589 |
Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (20 December 2021). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Cartilage, 13 (Issue 2_suppl), 862S-871. doi:10.1177/1947603519870855 |
Sanchez, C., Lambert, C., Zappia, J., Dubuc, J.-E., Delcour, J.-P., Dierckxsens, Y., & Henrotin, Y. (December 2021). Les extraits de Curcuma longa et de Boswellia serrata agissent par des mécanismes différents et complémentaires pour exercer une action anti-inflammatoire, anti-oxidante et anti-catabolique sur les chondrocytes : déchiffrage d’une étude transcriptomique. Revue du Rhumatisme, 88 (S1), 154. doi:10.1016/j.rhum.2021.10.242 |
Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (April 2021). Development of a primary skeletal muscle cell culture model from human muscle biopsies. Osteoarthritis and Cartilage, 29 (Suppl), 108. |
Zappia, J., Van der Cruyssen, R., Sanchez, C., Lausberg, C., Lambert, C., Florin, A., Elewaut, D., & Henrotin, Y. (April 2021). Osteomodulin Impacts Positively The Bone Remodeling Process In Osteoarthritis. Bone Reports, 14 (Suppl 1), 2352-1872. doi:10.1016/j.bonr.2021.100904 |
Zappia, J., Van der Cruyssen, R., Sanchez, C., Lausberg, C., Lambert, C., Florin, A., Elewaut, D., & Henrotin, Y. (April 2021). Osteomodulin impacts positively the bone remodeling process in osteoarthritis. Osteoarthritis and Cartilage, 29 (Suppl 1), 111. doi:10.1016/j.joca.2021.02.155 |
Lambert, C., Bellemère, G., Boyer, G., Ponelle, F., Bauer, T., Legeny, M.-C., Baudouin, C., & Henrotin, Y. (2021). Composition Analysis and Pharmacological Activity of Avocado/Soybean Unsaponifiable Products Used in the Treatment of Osteoarthritis. Frontiers in Pharmacology, 12, 781389. doi:10.3389/fphar.2021.781389 |
Lambert, C., Zappia, J., Sanchez, C., Florin, A., Dubuc, J.-E., & Henrotin, Y. (2021). The Damage-Associated Molecular Patterns (DAMPs) as Potential Targets to Treat Osteoarthritis: Perspectives From a Review of the Literature. Frontiers in Medicine, 7, 607186. doi:10.3389/fmed.2020.607186 |
Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (December 2020). Mise au point d’un modèle de culture original de cellules musculaires squelettiques à partir de biopsies musculaires humaines. Revue du Rhumatisme, Volume 87 (Supplément 1). doi:10.1016/j.rhum.2020.10.433 |
Florin, A., Lambert, C., Sanchez, C., Zappia, J., Durieux, N., Tieppo, A. M., Mobasheri, A., & Henrotin, Y. (2020). The secretome of skeletal muscle cells: A systematic review. Osteoarthritis and Cartilage Open. doi:10.1016/j.ocarto.2019.100019 |
Zappia, J., Joiret, M., Sanchez, C., Lambert, C., Geris, L., Muller, M., & Henrotin, Y. (2020). From translation to protein degradation as mechanisms for regulating biological functions: A review on the SLRP family in skeletal tissues. Biomolecules, 10, 80. doi:10.3390/biom10010080 |
Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (07 October 2019). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes [Paper presentation]. 15th World Congress of ICRS, Vancouver, Canada. |
Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (02 October 2019). Development of a muscle cell culture model from human muscle biopsies [Poster presentation]. EORS 2019, Maastricht, Netherlands. |
Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (June 2019). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Annals of the Rheumatic Diseases, 78 (Suppl 2), 1508. |
Florin, A., Lambert, C., Sanchez, C., Mobasheri, A., & Henrotin, Y. (03 May 2019). A systematic review of the secretome of skeletal muscle cells [Poster presentation]. Osteoarthritis Research Society International 2019, Toronto, Canada. doi:10.1016/j.joca.2019.02.677 |
Florin, A., Lambert, C., Sanchez, C., Durieux, N., Mobasheri, A., & Henrotin, Y. (04 April 2019). Sécrétome des cellules musculaires squelettiques: revue systématique de la littérature [Paper presentation]. Congrès Fragilité du sujet âgé, Paris, France. |
Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (April 2019). Syndecan-4 is increased in osteoarthritic knee, but nor ip or shoulder, articular hypertrophic chondrocytes. Osteoarthritis and Cartilage, 27 (Suppl 1), 159-160. |
Florin, A., Lambert, C., Sanchez, C., Mobasheri, A., & Henrotin, Y. (20 February 2019). The secretome of skeletal muscle cells: A systematic review [Poster presentation]. International Conference on Frailty & Sarcopenia Research, Miami, United States. |
Lambert, C., Borderie, D., Dubuc, J.-E., Rannou, F., & Henrotin, Y. (2019). Type II collagen peptide Coll2-1 is an actor of synovitis. Osteoarthritis and Cartilage, 27 (11), 1680-1691. doi:10.1016/j.joca.2019.07.009 |
Mobasheri, A., Lambert, C., & Henrotin, Y. (2019). Coll2-1 and Coll2-1NO2 as exemplars of collagen extracellular matrix turnover–biomarkers to facilitate the treatment of osteoarthritis? Expert Review of Molecular Diagnostics, 19 (9), 803-812. doi:10.1080/14737159.2019.1646641 |
Sanchez, C., Lambert, C., Dubuc, J., Bertrand, J., Pap, T., & Henrotin, Y. (November 2018). Le syndécan-4 est un marqueur de l’hypertrophie des chondrocytes du genou arthrosique. Revue du Rhumatisme, 85S, 327. |
Lambert, C., Borderie, D., Rannou, F., & Henrotin, Y. (June 2018). THE COLL2–1 PEPTIDE OF COLLAGEN TYPE II: A NEW ACTOR OF SYNOVITIS IN OSTEOARTHRITIS. Annals of the Rheumatic Diseases, 77 (supplement 2), 890. |
Legrand, C., Ahmed, U., Anwar, A., Rajpoot, K., Pasha, S., Lambert, C., Davidson, R. K., Clark, I. M., Thornalley, P. J., Henrotin, Y., & Rabbani, N. (June 2018). Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo. Arthritis Research and Therapy, 20 (1), 131. doi:10.1186/s13075-018-1636-6 |
Rabbani, N., Ahmed, U., Lambert, C., Legrand, C., Anwar, A., Rajpoot, K., Pasha, S., Davidson, R., Clark, I., Thornalley, P., & Henrotin, Y. (June 2018). GLUCOSEPANE : A NEW BIOMARKER OF THE SEVERITY OF OSTEOARTHRITIS. Annals of the Rheumatic Diseases, 77 (supplement 2), 181. |
Sanchez, C., Mazzucchelli, G., Comblain, F., Lambert, C., De Pauw, E., & Henrotin, Y. (June 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Annals of the Rheumatic Diseases, 77 (supplement 2), 894. |
Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (April 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Osteoarthritis and Cartilage, 26 (supplement 1), 89. doi:10.1016/j.joca.2018.02.192 |
Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (2018). Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot study. PLoS ONE, 13 (3), 0194591. doi:10.1371/journal.pone.0194591 |
Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (December 2017). L’analyse protéomique du sécrétome des ostéoblastes fournis de nouvelles indications sur les mécanismes de la sclérose sous-chondrale dans l’arthrose. Revue du Rhumatisme, 84 (S1), 295. |
Comblain, F., Lambert, C., Sanchez, C., Dubuc, J.-E., Barthélémy, N., Lefebvre, M., Schwartz, C., Lesponne, I., Serisier, S., Feugier, A., Balligand, M., & Henrotin, Y. (May 2017). In vitro and clinical studies of a new nutraceuticals mixture for the management of osteoarthritis [Poster presentation]. Young Researchers in Life Sciences, Paris, France. |
Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (27 April 2017). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs [Poster presentation]. OARSI World Congress on Osteoarthritis, Caesar's Palace Las Vegas, United States. |
Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (April 2017). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs. Osteoarthritis and Cartilage, 25, 314-s315. |
Lambert, C., Borderie, D., Rannou, F., & Henrotin, Y. (2017). Le peptide Coll2-1 du collagène de type II : un nouvel acteur de la synovite dans l’arthrose. Revue du Rhumatisme, 84S, 50. |
Lambert, C., Legrand, C., Ahmed, U., Anwar, A., Rajpoot, K., Pasha, S., Davidson, R., Clark, I., Thornalley, P., Rabbani, N., & Henrotin, Y. (2017). Le glucosépane : un nouveau marqueur de la sévérité de l’arthrose. Revue du Rhumatisme, 84S, 102. |
Legrand, C., Lambert, C., Comblain, F., Sanchez, C., & Henrotin, Y. (2017). Review of soluble biomarkers of osteoarthritis: lessons from animal model. Cartilage, 1-23. doi:10.1177/1947603516656739 |
Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (16 November 2016). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs [Poster presentation]. Bioforum Proceedings 2016, Liège, Belgium. |
Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (November 2016). Étude de l’évolution de la pathologie arthrosique et des propriétés mécaniques du cartilage sur un modèle d’arthrose spontanée chez le cobaye Dunkin-Hartley. Revue du Rhumatisme, 83S, 209-A210. doi:10.1016/S1169-8330(16)30512-9 |
Henrotin, Y., Lambert, C., Borderie, D., & Rannou, F. (23 June 2016). Coll2-1 peptide and its nitrated form as therapeutic targets for osteoarthritis treatment. |
Comblain, F., Dubuc, J.-E., Lambert, C., Sanchez, C., Lesponne, I., Serisier, S., & Henrotin, Y. (2016). Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. PLoS ONE. doi:10.1371/journal.pone.0156902 |
Comblain, F., Dubuc, J.-E., Lambert, C., Sanchez, C., Lesponne, I., Serisier, S., & Henrotin, Y. (April 2016). Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. Osteoarthritis and Cartilage, 24 (Supp 1), 353. |
Legrand, C., Lambert, C., Comblain, F., Sanchez, C., & Henrotin, Y. (April 2016). Review of soluble biomarkers of osteoarthritis: lessons from animal model. Osteoarthritis and Cartilage, 24 (suppl 1), 88. |
Sanchez, C., Lambert, C., Comblain, F., Legrand, C., & Henrotin, Y. (April 2016). Osteoarthritic sclerotic subchondral osteoblasts secreted elevated concentration of fibulin-3 fragments in vitro. Osteoarthritis and Cartilage, 24 (suppl 1), 83. |
Comblain, F., Lambert, C., Lesponne, I., Sanchez, C., Dubuc, J.-E., & Henrotin, Y. (2015). Identification d’un spectre de cibles thérapeutiques d’un nouveau traitement pour l’arthrose composé d’extrait de curcuminoïdes, de collagène hydrolysé et d’extrait de thé vert. Revue du Rhumatisme. |
Comblain, F., Lambert, C., Lesponne, I., Sanchez, C., Dubuc, J.-E., & Henrotin, Y. (2015). Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed By Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. Arthritis and Rheumatology, 67 (Suppl10). |
Henrotin, Y., Lambert, C., & Richette, P. (April 2014). Importance of synovitis in osteoarthritis: Evidence for the use of glycosaminoglycans against synovial inflammation. Seminars in Arthritis and Rheumatism, 43 (5), 579-87. doi:10.1016/j.semarthrit.2013.10.005 |
Henrotin, Y., Pesesse, L., & Lambert, C. (February 2014). Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis. Therapeutic Advances in Musculoskeletal Disease, 6 (1), 20-34. doi:10.1177/1759720X13514669 |
Lambert, C., Dubuc, J.-E., Montell, E., Verges, J., Munaut, C., Noël, A., & Henrotin, Y. (2014). Gene expression pattern of synovial cells from inflammatory and normal areas of osteoarthritis synovial membrane. Arthritis and Rheumatism, sous presse. doi:10.1002/art.38315 |
Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (23 November 2013). EFFECTS OF CHONDROITIN SULFATE ON THE GENE EXPRESSION PROFILE IN THE INFLAMED SYNOVIAL MEMBRANE [Paper presentation]. BMJD 2013, Brussels, Belgium. |
Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (23 November 2013). EFFECTS OF CHONDROITIN SULFATE ON THE GENE EXPRESSION PROFILE IN INTERLEUKIN-1Β STIMULATED SYNOVIAL FIBROBLAST CELLS CULTURES [Paper presentation]. BMJD 2013, Brussels, Belgium. |
Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (November 2013). SYNERGISTIC BENEFICIAL EFFECTS OF CURCUMA EXTRACT, GREEN TEA EXTRACT AND HYDROLYZED COLLAGEN IN BOVINE CHONDROCYTES IN MONOLAYER CULTURE [Poster presentation]. Bone, Muscle & Joint Diseases 2013, Brussels, Belgium. |
Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (02 October 2013). Synergistic beneficial effects of curcuma extract, green tea extract and hydrolysed collagen in bovine chondrocytes in monolayer culture [Paper presentation]. Waltham International Nutritional Sciences Symposium 2013, Portland, United States - Oregon. |
Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (April 2013). Effects of chondroitin sulfate on the gene expression profile in the inflamed synovial membrane. Osteoarthritis and Cartilage, 21 (Supplement April 2013). |
Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (April 2013). Effects of chondroitin sulfate on the gene expression profile in IL-1β stimulated synovial fibroblast cells cultures. Osteoarthritis and Cartilage, 21 (Supplement April 2013). |
Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. (April 2013). Investigation of potential new targets for the diagnosis and/or the treatment of osteoarthritis. Osteoarthritis and Cartilage, 21 (Supplement April 2013). |
Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (2013). Effets bénéfiques et synergiques du curcuma, du thé vert et du collagène hydrolysé sur des chondrocytes bovins cultivés en monocouche. Revue du Rhumatisme, 80S, 130. |
Henrotin, Y., & Lambert, C. (2013). Chondroitin and glucosamine in the management of osteoarthritis: an update. Current Rheumatology Reports. doi:10.1007/s11926-013-0361-z |
Vandenbosch, R., Chocholova, E., Robe, P., Wang, Y., Lambert, C., Moonen, G., Lallemend, F., Malgrange, B., & Hadjab, S. (2013). A role for the canonical nuclear factor-κB pathway in coupling neurotrophin-induced differential survival of developing spiral ganglion neurons. Frontiers in Cellular Neuroscience, 7, 1-10. doi:10.3389/fncel.2013.00242 |
Lambert, C., Dubuc, J.-E., Hennuy, B., Montell, E., Vergés, J., & Henrotin, Y. (17 July 2012). Expression of specific pathways in the inflamed synovial membrane of osteoarthritis patient: Identification of new potential key intermediates [Poster presentation]. 6th European congress of pharmacology, Granada, Spain. |
Lambert, C., Dubuc, J.-E., & Henrotin, Y. (19 April 2012). An original methodology to study the synovial tissue in OA patient [Poster presentation]. Biomedica, Liège, Belgium. |
Lambert, C., Dubuc, J.-E., Hennuy, B., Montell, E., Vergés, J., & Henrotin, Y. (April 2012). Expression of specific pathways in the inflamed synovial membrane of osteoarthritis patient: Identification of new potential key intermediates. Osteoarthritis and Cartilage, 20 (Supplement 1), 56. |
Lambert, C., Mathy-Hartert, M., Dubuc, J., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. (March 2012). Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Research and Therapy, 14 (2), 58. doi:10.1186/ar3771 |
Henrotin, Y., Lambert, C., Couchourel, D., Ripoll, C., & Chiotelli, E. (2011). Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthritis and Cartilage, 19 (1), 1-21. doi:10.1016/j.joca.2010.10.017 |
Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (October 2010). Synovium angiogenesis in osteoarthritis: a new therapy target for chondroitin sulfate. Osteoarthritis and Cartilage, 18, 45-S46. doi:10.1016/S1063-4584(10)60113-6 |
Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (September 2010). Synovium angiogenesis in osteoarthritis: a new therapy target for chondroitin sulfate [Poster presentation]. 2010 World Congress on Osteoarthritis, Bruxelles, Belgium. |
Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (September 2010). La chondroitine sulfate stimule la production des facteurs anti angiogéniques TSP-1 et VEGI par les synoviocytes arthrosiques : un nouveau mécanisme d’action pour cette molécule [Poster presentation]. 23e congrès français de rhumatologie, Paris, France. |
Henrotin, Y., Mathy, M., Sanchez, C., & Lambert, C. (2010). Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. Therapeutic Advances in Musculoskeletal Disease, 2 (6), 335-348. doi:10.1177/1759720X10383076 |
Lambert, C., Mathy, M., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (2010). Etude du phenotype des synoviocytes fibroblast-like isolés à partir de tissu synovial arthrosique. Revue du Rhumatisme, 77, 105. |
Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (2010). La chondroitine sulfate stimule la production des facteurs anti angiogéniques TSP-1 et VEGI par les synoviocytes arthrosiques : un nouveau mécanisme d’action pour cette molécule. Revue du Rhumatisme, 77, 251-A252. |
Mathy, M., Jacquemond-Collet, I., Priem, F., Sanchez, C., Lambert, C., & Henrotin, Y. (December 2009). Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflammation Research, 58, 899-908. doi:10.1007/s00011-009-0063-1 |
Lambert, C. (2008). Régulation de l'expression du gène de l'ostéoprotégérine dans les cellules ostéosarcomateuses MG-63 [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/56850 |
Lambert, C., Oury, C., Dejardin, E., Chariot, A., Piette, J., Malaise, M., Merville, M.-P., & Franchimont, N. (September 2007). Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells. Journal of Bone and Mineral Research, 22 (9), 1350-1361. doi:10.1359/jbmr.070508 |
Fischer, A., Karasi, J. C., Kibibi, D., Omes, C., Lambert, C., Uwayitu, A., Hemmer, R., Ende, J., Schmit, J.-C., & Arendt, V. (2006). Antiviral efficacy and resistance in patients on antiretroviral therapy in Kigali, Rwanda: the real-life situation in 2002. HIV Medicine, 7 (1), 64-6. doi:10.1111/j.1468-1293.2005.00338.x |
Franchimont, N., Lambert, C., Huynen, P., Ribbens, C., Relic, B., Chariot, A., Bours, V., Piette, J., Merville, M.-P., & Malaise, M. (2005). Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis and Rheumatism, 52 (1), 84-93. doi:10.1002/art.20727 |